CRSP

Crispr Therapeutics Ag Earnings

$35.61

Earnings Summary

Revenue	$0Mn
Net Profits	$-136Mn
Net Profit Margins	-Inf%

Highlights

Revenue:

Crispr Therapeutics Ag’s revenue fell -100% since last year same period to $0Mn in the Q1 2025. On a quarterly growth basis, Crispr Therapeutics Ag has generated -100% fall in its revenue since last 3-months.

Net Profits:

Crispr Therapeutics Ag’s net profit fell -16.64% since last year same period to $-136Mn in the Q1 2025. On a quarterly growth basis, Crispr Therapeutics Ag has generated -264.49% fall in its net profits since last 3-months.

Net Profit Margins:

Crispr Therapeutics Ag’s net profit margin fell -Inf% since last year same period to -Inf% in the Q1 2025. On a quarterly growth basis, Crispr Therapeutics Ag has generated -Inf% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Crispr Therapeutics Ag post its latest quarter earnings

EPS Estimate Current Quarter	-1.28
EPS Estimate Current Year	-1.28

Highlights

EPS Estimate Current Quarter:

Crispr Therapeutics Ag’s earning per share (EPS) estimates for the current quarter stand at -1.28 - a -7.69% fall from last quarter’s estimates.

EPS Estimate Current Year:

Crispr Therapeutics Ag’s earning per share (EPS) estimates for the current year stand at -1.28.

Key Ratios

Key ratios of the Crispr Therapeutics Ag post its Q1 2025 earnings

Earning Per Share (EPS)

-1.58

Highlights

Earning Per Share (EPS):

Crispr Therapeutics Ag’s earning per share (EPS) fell -10.49% since last year same period to -1.58 in the Q1 2025. This indicates that the Crispr Therapeutics Ag has generated -10.49% annual rate of fall in its earning per share (EPS) in the last 4 quarters.